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Correction to: Nature Communications; https://doi.org/10.1038/s41467-018-06302-1; published online 4 October 2018
The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-
Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and HTML
versions of the Article. Furthermore, In the original HTML version of this Article, the order of authors within the author list was
incorrect. The consortium PRACTICAL consortium was incorrectly listed after Bogdan Pasaniuc and should have been listed after
Kathryn L. Penney. This error has been corrected in the HTML version of the Article; the PDF version was correct at the time of
publication.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
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